Population
1 51-year-old white man with a high-grade unresectable primary cardiac sarcoma
Design
Case_report
Follow-up
more than 5 years
Authors
Loading...
Hypothesis-generating for unresectable cardiac sarcoma; prospective trials required before clinical adoption.
Hyperfractionated radiotherapy combined with a radiosensitizer may offer long-term disease-free survival in patients with unresectable primary cardiac sarcoma.
Movsas et al. (1998) studied this question.